[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE60329838D1 - Verwendung von alpha-s2 casein vorläufer-abgeleiteten peptiden - Google Patents

Verwendung von alpha-s2 casein vorläufer-abgeleiteten peptiden

Info

Publication number
DE60329838D1
DE60329838D1 DE60329838T DE60329838T DE60329838D1 DE 60329838 D1 DE60329838 D1 DE 60329838D1 DE 60329838 T DE60329838 T DE 60329838T DE 60329838 T DE60329838 T DE 60329838T DE 60329838 D1 DE60329838 D1 DE 60329838D1
Authority
DE
Germany
Prior art keywords
peptide
alpha
casein
casein precursor
derived peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60329838T
Other languages
English (en)
Inventor
John Arthur Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pepsyn Ltd
Original Assignee
Pepsyn Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pepsyn Ltd filed Critical Pepsyn Ltd
Application granted granted Critical
Publication of DE60329838D1 publication Critical patent/DE60329838D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60329838T 2002-04-24 2003-04-02 Verwendung von alpha-s2 casein vorläufer-abgeleiteten peptiden Expired - Lifetime DE60329838D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0209384.7A GB0209384D0 (en) 2002-04-24 2002-04-24 Peptide composition
PCT/GB2003/001439 WO2003091274A2 (en) 2002-04-24 2003-04-02 Use of alpha-s2 casein precursor-derived peptided

Publications (1)

Publication Number Publication Date
DE60329838D1 true DE60329838D1 (de) 2009-12-10

Family

ID=9935427

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60329838T Expired - Lifetime DE60329838D1 (de) 2002-04-24 2003-04-02 Verwendung von alpha-s2 casein vorläufer-abgeleiteten peptiden

Country Status (8)

Country Link
US (2) US20060019884A1 (de)
EP (1) EP1501538B1 (de)
JP (1) JP2005531539A (de)
AT (1) ATE446766T1 (de)
AU (1) AU2003222959A1 (de)
DE (1) DE60329838D1 (de)
GB (1) GB0209384D0 (de)
WO (1) WO2003091274A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209384D0 (en) 2002-04-24 2002-06-05 Pepsyn Ltd Peptide composition
CN102316886B (zh) 2008-12-15 2014-06-18 可尔必思株式会社 抗皮肤老化肽

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
JPH03255095A (ja) 1990-03-02 1991-11-13 Kanebo Ltd カゼインペプチド
EP0457565B1 (de) 1990-05-18 1997-07-30 Morinaga Milk Industry Co., Ltd. Milchproteinhydrolysate und Zusammensetzungen zur Verwendung als Haar- und Hautbehandlungsmittel
AUPN271295A0 (en) 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
DK0545946T3 (da) 1990-07-13 2005-05-23 Gropep Ltd Vækstfremmende middel
FR2673374A1 (fr) 1991-03-01 1992-09-04 Oreal Composition cosmetique contenant comme ingredient actif un peptide a activite opiouide.
CH684773A5 (fr) * 1992-12-28 1994-12-30 Nestle Sa Composition alimentaire anti-cariogène.
JPH06211689A (ja) 1993-01-19 1994-08-02 Kanebo Ltd 鎮静剤及び精神安定用食品
US5965536A (en) * 1993-12-15 1999-10-12 Board Of Regents, The University Of Texas System Methods of inhibiting CXC intercrine molecules
AUPM534794A0 (en) 1994-04-28 1994-05-19 Gropep Pty Ltd Modified milk growth factor
US5948763A (en) * 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
GB9522302D0 (en) * 1995-10-31 1996-01-03 Univ Liverpool Growth promoters
CN1189153C (zh) 1997-05-19 2005-02-16 科尔加特·帕尔莫利弗公司 用于牙齿再矿化的口用组合物和再矿化方法
JP3255095B2 (ja) 1997-09-30 2002-02-12 日本電気株式会社 研磨液および研磨方法
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
CA2296311A1 (en) * 1999-01-28 2000-07-28 Universite Laval Enzymatic hydrolysate of milk proteins
GB0016189D0 (en) * 2000-06-30 2000-08-23 Pepsyn Ltd Cosmetic composition
GB0209384D0 (en) 2002-04-24 2002-06-05 Pepsyn Ltd Peptide composition

Also Published As

Publication number Publication date
AU2003222959A1 (en) 2003-11-10
AU2003222959A8 (en) 2003-11-10
US7786081B2 (en) 2010-08-31
JP2005531539A (ja) 2005-10-20
US20070160558A1 (en) 2007-07-12
EP1501538A2 (de) 2005-02-02
WO2003091274A2 (en) 2003-11-06
EP1501538B1 (de) 2009-10-28
WO2003091274A3 (en) 2003-12-24
GB0209384D0 (en) 2002-06-05
ATE446766T1 (de) 2009-11-15
US20060019884A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
ATE309358T1 (de) Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein
DK323587D0 (da) Protein
AU6410201A (en) Peptide composition
ATE257859T1 (de) Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit
ATE278710T1 (de) Antimikrobiell wirksame peptide
RS51325B (sr) Polipeptidi koji imaju antimikrobno dejstvo i polinukleotidi koji ih kodiraju
ATE393631T1 (de) Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen
ATE5314T1 (de) Pharmakologisch aktive peptide und deren zusammensetzungen.
DK39591A (da) Peptidforbindelser
DE60329838D1 (de) Verwendung von alpha-s2 casein vorläufer-abgeleiteten peptiden
ATE510008T1 (de) Entzündungshemmende peptide
NZ591825A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
GB0207644D0 (en) Peptides and their use
JP2005518355A5 (de)
DE60108739D1 (de) Herstellung von n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanin-1-methylester durch verwendung vom l-alpha-aspartyl-l-phenylalanin-1-methylester als vorläufer
ATE92078T1 (de) Pharmakologisch aktive peptide.
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
ATE452139T1 (de) Peptid-köder zur herstellung von medikamenten, die für die prävention oder behandlung von autoimmunerkrankungen bzw. problemen, die mit dem auftreten von gegen exogene proteine gerichteten antikörpern in zusammenhang stehen, bestimmt sind
WO2004048409A3 (en) Mutants of the tumor necrosis factor alpha with deletion of n-terminal amino acids
ATE420890T1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ATE260934T1 (de) Therapeutische peptide aus untersequenzen von bpi
WO2003035856A3 (en) Protein with kinase activity

Legal Events

Date Code Title Description
8364 No opposition during term of opposition